Salubris
Salubris is a company. It is a public company in Shenzhen, China. It was founded in 1998 and its current CEO is Jie Yan. It is part of the Health Care sector, specifically in the Health Care Equipment & Supplies industry.
Key facts
- city: Shenzhen
- country: China
- employees: 3,517 people
- revenues: 538.2M $
- company type: public
- sector: Health Care
- industry: Health Care Equipment & Supplies
- foundation year: 1998
- CEO: Jie Yan
- ESG score: Try Pro to see estimate
Extract data
Download datasets about Salubris:
Dataset of stocks from Salubris:
Salubris is one of the companies in China, companies in Health Care Equipment & Supplies, companies in Health Care, companies in Shenzhen and 3,456,808 companies in our database.
Talking Points
- 深圳信立泰药业股份有限公司
- Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of medicines for cardiovascular, anti-diabetic, antineoplastic, and orthopedic therapeutic in China. It offers cardiovascular and cerebrovascular products, such as allisartan isoproxil, benazepril hydrochloride, desloratadine, and clopidogrel bisulfate tablets, as well as bivalirudin and pamidronate disodium injections; recombinant SeV-hFGF2/dF Injection for the treatment of diabetic foot disease; and anti-tumor and orthopedics medicines. The company also provides anti-infection products comprising cefonicid sodium, ceftazidime, ceftriaxone sodium, cefonicid sodium, cefminox sodium, cefuroxime sodium, cefepime hydrochloride, and cefodizime sodium injections, as well as azithromycin dispersible and levetiracetam tablets. In addition, it offers biotechnological drugs, such as recombinant protein and monoclonal antibody drugs. Further, the company is involved in import, licensing-in, and licensing-out medicines for Europe markets. The company was founded in 1998 and is headquartered in Shenzhen, China.